Three dimensional staging of breast cancer
暂无分享,去创建一个
[1] M. Silverstein,et al. Axillary lymph node dissection for t1a breast carcinoma. Is it indicated? , 1994, Cancer.
[2] T. Stamey,et al. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate , 1990, Cancer.
[3] Max H. Myers,et al. Manual for Staging of Cancer , 1992 .
[4] W. McGuire,et al. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. , 1992, The New England journal of medicine.
[5] K. Forde,et al. Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995: treatment of nude mouse xenografts. , 1989, Surgery.
[6] J. Spratt,et al. Growth rates of primary breast cancers , 1979, Cancer.
[7] W. McGuire,et al. Prognostic factors and therapeutic decisions in axillary node-negative breast cancer. , 1992, Annual review of medicine.
[8] Axillary lymph node dissection for t1a breast carcinoma. Is it indicated? , 1994 .
[9] L. Norton,et al. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] E. Atkinson,et al. Tumor volume, nodal status, and metastasis in breast cancer in women. , 1986, Journal of the National Cancer Institute.
[11] L. Norton,et al. Potential innovations in scheduling of cancer chemotherapy. , 1991, Important advances in oncology.
[12] J. Seidman,et al. Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis , 1995, Cancer.
[13] C. D. HAAGENSEN,et al. Diseases of the Breast , 1972 .